The novel use of the human nasal epithelial cell line RPMI 2650 as an in vitro model to study the influence of allergens and cytokines on transforming growth factor-β gene expression and protein release
Article first published online: 21 JUN 2005
Clinical & Experimental Allergy
Volume 35, Issue 6, pages 811–819, June 2005
How to Cite
Salib, R. J., Lau, L. C. and Howarth, P. H. (2005), The novel use of the human nasal epithelial cell line RPMI 2650 as an in vitro model to study the influence of allergens and cytokines on transforming growth factor-β gene expression and protein release. Clinical & Experimental Allergy, 35: 811–819. doi: 10.1111/j.1365-2222.2005.02258.x
- Issue published online: 21 JUN 2005
- Article first published online: 21 JUN 2005
- Submitted 31 October 2004; revised 11 February 2005; accepted 14 March 2005
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- New Users: Please register, then proceed to purchase the article.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!